×
About 6,068 results

ALLMedicine™ Retinoblastoma Center

Research & Reviews  2,182 results

MRI can reliably differentiate optic nerve inflammation from tumor invasion in retinobl...
https://doi.org/10.1016/j.ophtha.2022.06.013
Ophthalmology Jansen RW, van der Heide S et. al.

Jun 26th, 2022 - To investigate prevalence and MRI phenotype of retinoblastoma-associated orbital cellulitis. Additionally, this study aimed to identify postlaminar optic nerve enhancement patterns differentiating between inflammation and tumor invasion. A monocen...

Retinoblastoma Biomarker Study
https://clinicaltrials.gov/ct2/show/NCT00342797

Jun 24th, 2022 - Retinoblastoma is a rare pediatric ocular tumor caused by germline and/or somatic mutations in the tumor suppressor gene RB1. Survivors of retinoblastoma, particularly those with the hereditary form of the disease (germline RB1 mutations) are high...

The Anaphase Promoting Complex/ cyclosome co-activator, Cdh1, is a novel target of huma...
https://doi.org/10.1093/carcin/bgac057
Carcinogenesis Jaiswal N, Nandi D et. al.

Jun 24th, 2022 - The transforming properties of the high risk human papillomavirus (HPV) E7 oncoprotein are indispensable for driving the virus life cycle and pathogenesis. Besides inactivation of the retinoblastoma family of tumor suppressors as part of its oncog...

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
https://clinicaltrials.gov/ct2/show/NCT04941274

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor, caused by Kaposi sarcoma-associated herpesvirus, that most frequently involves the skin, but may also involve lymph nodes, lungs, bone and gastrointestinal tract. It is mo...

see more →

Guidelines  1 results

Guidelines for imaging retinoblastoma: imaging principles and MRI standardization.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256324
Pediatric Radiology; de Graaf P, Göricke S et. al.

Aug 19th, 2011 - Retinoblastoma is the most common intraocular tumor in children. The diagnosis is usually established by the ophthalmologist on the basis of fundoscopy and US. Together with US, high-resolution MRI has emerged as an important imaging modality for ...

see more →

Drugs  19 results see all →

Clinicaltrials.gov  129 results

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
https://clinicaltrials.gov/ct2/show/NCT04941274

Jun 24th, 2022 - Background: Kaposi Sarcoma (KS) is a multicentric angioproliferative tumor, caused by Kaposi sarcoma-associated herpesvirus, that most frequently involves the skin, but may also involve lymph nodes, lungs, bone and gastrointestinal tract. It is mo...

Retinoblastoma Biomarker Study
https://clinicaltrials.gov/ct2/show/NCT00342797

Jun 24th, 2022 - Retinoblastoma is a rare pediatric ocular tumor caused by germline and/or somatic mutations in the tumor suppressor gene RB1. Survivors of retinoblastoma, particularly those with the hereditary form of the disease (germline RB1 mutations) are high...

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
https://clinicaltrials.gov/ct2/show/NCT01783535

Jun 10th, 2022 - Participants will be stratified into four main treatment groups, depending on whether retinoblastoma is present in one or both eyes and disease grouping [early or advanced, Reese-Ellsworth (R-E) group I-V, and International Classification A-E]. Ad...

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma
https://clinicaltrials.gov/ct2/show/NCT03284268

Jun 8th, 2022 - Phase I study, single site, open label with dose escalation, for evaluate safety and the oncolitic Adenovirus VCN-01 activity in patients with refractory retinoblastoma.

Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma
https://clinicaltrials.gov/ct2/show/NCT02097134

Jun 7th, 2022 - PRIMARY OBJECTIVES: I. To study the feasibility of delivering melphalan directly into the ophthalmic artery in children with newly diagnosed unilateral group D retinoblastoma, who would otherwise be considered for enucleation. SECONDARY OBJECTIVES...

see more →

News  89 results

Net Guides: Childhood Tumors
https://www.onclive.com/view/net-guides-childhood-tumors

Mar 15th, 2022 - //THE ONLINE ONCOLOGIST™ American Society of Pediatric Hematology/Oncology The American Society of Pediatric Hematology/Oncology (ASPHO) is a multidisciplinary organization that works to promote the care of children and adolescents with blo...

Brachytherapy Represents a Potential Strategy in AYA Patients With Rhabdomyosarcoma
https://www.onclive.com/view/brachytherapy-represents-a-potential-strategy-in-aya-patients-with-rhabdomyosarcoma

Feb 9th, 2022 - Although brachytherapy (BT) is rarely utilized as a treatment for pediatric and adolescent/young adult (AYA) patients in the United States, AYA patients with rhabdomyosarcoma (RMS) treated with BT had favorable survival outcomes, according to find...

Trilaciclib Prior to Myelosuppressive Chemo Reduces Need for Supportive Care in Small Cell Lung Cancer
https://www.onclive.com/view/trilaciclib-prior-to-myelosuppressive-chemo-reduces-need-for-supportive-care-in-small-cell-lung-cancer

Oct 6th, 2021 - Trilaciclib administered prior to chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC) helped to reduce chemotherapy-induced myelosuppression and limit the need for granulocyte colony-stimulating factors (G-CSF), erythrop...

iPhone Flash Helps Nurse Identify Her Infant Son's Retinoblastoma
https://www.medscape.com/viewarticle/957441

Aug 27th, 2021 - Josie Rock was taking pictures of her 3-month-old son Asher when the lighting in the room suddenly dimmed, initiating the flash on her iPhone. Asher's eyes opened wide, but instead of his pupils glowing red, as they normally do when a flash is use...

FDA Approval of Ribociclib for Metastatic Breast Cancer
https://www.onclive.com/view/fda-approval-of-ribociclib-for-metastatic-breast-cancer

Apr 2nd, 2021 - Transcript:Adam M. Brufsky, MD, PhD: Hello, and thank you for joining us in this OncLive Peer Exchange® titled Questions and Controversies in Treating Breast Cancer. Evidence-based management of breast cancer has become increasingly complex owing ...

see more →

Patient Education  7 results see all →